Point72 Hong Kong’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Point72 Hong Kong’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,055	Closed	-$342K	–	1846
2022 Q3	$342K	Sell	19,055 -1,335	-7%	-$17.5K	0.01%	895
2022 Q2	$196K	Buy	+20,390	New	+$256K	0.01%	975
2022 Q1	–	Sell	-2,387	Closed	-$40K	–	2477
2021 Q4	$40K	Buy	+2,387	New	+$39.1K	﹤0.01%	1393
2021 Q3	–	Sell	-1,703	Closed	-$11K	–	2565
2021 Q2	$11K	Buy	+1,703	New	+$11K	﹤0.01%	1735
2017 Q1	–	Sell	-1,713	Closed	-$8K	–	1068
2016 Q4	$8K	Buy	+1,713	New	+$50.8K	0.01%	680

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Point72 Hong Kong's ISEE Position: Q4 2022 in Review

Point72 Hong Kong sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 19,055 shares — an estimated $342K sold.

Point72 Hong Kong first reported a position in ISEE in Q4 2016 and held it in 5 quarters. The position peaked at $342K in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Point72 Hong Kong reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 19,055 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $342K.
Point72 Hong Kong first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 5 quarters.
Point72 Hong Kong's IVERIC bio, Inc. Common Stock position peaked at $342K in Q3 2022.
225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.